Clinical Oncology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines Risk Factors
Researchers from University of Tsukuba describe findings in cancer vaccines risk factors
July 13th, 2009
Current study results from the report, 'Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer,' have been published. "To obtain baseline data for human papillomavirus (HPV) screening and vaccination in Japan, we analyzed HPV DNA data from 2282 Japanese women (1517 normal cytology, 318 cervical intraepithelial neoplasia [CIN] grade 1, 307 CIN2-3, and 140 invasive cervical cancer [ICC]) that visited the University of Tsukuba Hospital or Ibaraki Seinan Medical Center Hospital for screening or treatment of cervical diseases between 1999 and 2007. An L1-based PCR method was used for individual HPV genotyping," scientists writing...
Source: Clinical Oncology Week (2009-07-13)
|
